WuXi XDC Cayman Inc.
WuWi XDC Cayman Inc is a leading contract research, development and manufacturing organization focusing on the global antibody-drug conjugate and broader bioconjugate market dedicated to providing integrated and comprehensive services, covering bioconjugate discovery, research, development and manufacturing ranked no. 2 globally and no. 1 in China.
Sharlife Shariah Status :
Yes
| Allocation | Shares | % |
|---|---|---|
| Hong Kong Offer Shares | ||
| International Offer Shares |
Income Statement
| 31/12/2020 | 31/12/2021 | 31/12/2022 | % Growth | |
|---|---|---|---|---|
| Revenue | ||||
| Other Income | ||||
| Interest Income | ||||
| Profit After Tax | ||||
| PAT Margin % |
Balance Sheet
| 31/12/2020 | 31/12/2021 | 31/12/2022 | % Growth | |
|---|---|---|---|---|
| Non-current Assets | ||||
| Current Assets | ||||
| Non Current Liabilities | ||||
| Current Liabilities | ||||
| Deferred Liabilities | ||||
| Total Assets | ||||
| Total Liabilities |
Capital & Reserves
| 31/12/2020 | 31/12/2021 | 31/12/2022 | % Growth | |
|---|---|---|---|---|
| Share Capital | ||||
| Retained Earnings | ||||
| Reserves | ||||
| Working Capital | ||||
| Shareholder Fund |
Ratio
0 = Lowest | 5 = Highest
| 31/12/2020 | Score | 31/12/2021 | Score | 31/12/2022 | Score | % Growth | |
|---|---|---|---|---|---|---|---|
| Current Ratio (Liquidity) | |||||||
| Debt Ratio (Leverage) | |||||||
| Gearing Ratio (Leverage) | |||||||
| Return on Capital Employed | |||||||
| Total Assets Turnover |
Altman-Z
| 31/12/2020 | 31/12/2021 | 31/12/2022 | Overall weighted score |
|---|---|---|---|
| Company P/E ratio | |
|---|---|
| Peers | P/E |
| Checklist | Remarks |
|---|---|
| Revenue |